Bioengineering Liver Organoids for Diseases Modelling and Transplantation

Abstract

Organoids as three-dimension (3D) cellular organizations partially mimic the physiological functions and micro-architecture of native tissues and organs, holding great potential for clinical applications. Advances in the identification of essential factors including physical cues and biochemical signals for controlling organoid development have contributed to the success of growing liver organoids from liver tissue and stem/progenitor cells. However, to recapitulate the physiological properties and the architecture of a native liver, one has to generate liver organoids that contain all the major liver cell types in correct proportions and relative 3D locations as found in a native liver. Recent advances in stem-cell-, biomaterial- and engineering-based approaches have been incorporated into conventional organoid culture methods to facilitate the development of a more sophisticated liver organoid culture resembling a near to native mini-liver in a dish. However, a comprehensive review on the recent advancement in the bioengineering liver organoid is still lacking. Here, we review the current liver organoid systems, focusing on the construction of the liver organoid system with various cell sources, the roles of growth factors for engineering liver organoids, as well as the recent advances in the bioengineering liver organoid disease models and their biomedical applications.

Biomimetic Scaffolds—A Novel Approach to Three Dimensional Cell Culture Techniques for Potential Implementation in Tissue Engineering

“…Organoids are often referred to as mini-organs, and current research is focused on creating fully functional organs on a mini-scale. Examples include ‘mini-guts’ [ 53 ], ‘mini-hearts’ [ 54 ], and ‘mini-livers’ [ 55 ]. The name ‘organoid’ accurately describes a miniaturised model of an entire organ.…”

Exploiting Matrix Stiffness to Overcome Drug Resistance

“…To overcome these problems, another approach, namely fully synthetic materials, is used to mimic the ECM. This approach is based on mainly using bioinert and biocompatibility polymers such as polyethylene glycol (PEG), polycaprolactone (PCL), , poly(vinyl alcohol) (PVA), and polyacrylamide (PA) , with various functionalization techniques and functional groups. − The main advantage of this approach is the controllability of the composition. It has very low batch to batch variations due to high yield bioconjugation techniques.…”